Used in research and therapeutic development for its ability to target Ly6E, a protein involved in immune regulation and cancer progression. Shows potential in oncology, particularly in studies related to tumor growth inhibition and immune cell modulation. Investigated for its role in enhancing anti-tumor immune responses and as a candidate in antibody-based therapies for solid tumors and hematological malignancies. Also serves as a reference standard in immunoassays and antibody validation workflows.